Please check your internet connection and try again.
## Lorazepam (Representative Benzodiazepine)
### Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties. It acts by potentiating the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor.
### Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Preoperative sedation
* Management of seizures (status epilepticus)
* Management of agitation
### Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Preoperative Sedation:** 2 mg to 4 mg orally 2 hours before surgery.
* **Status Epilepticus:** 2 mg to 4 mg IV or IM, may repeat after 5 to 10 minutes up to a maximum of 8 mg in a 12-hour period. For refractory status epilepticus, higher doses may be considered under close medical supervision.
* **Agitation:** 0.5 mg to 2 mg orally or IM every 4 to 6 hours as needed. IV administration for agitation should be done cautiously due to potential for respiratory depression.
### Pediatric Dosing
Dosing in pediatric patients is highly variable and should be individualized based on age, weight, and clinical condition.
* **Anxiety:** Not typically recommended for routine use in children. Specific doses are not established and should be determined by a specialist.
* **Status Epilepticus:** 0.05 mg/kg IV or IM, not to exceed 2 mg per dose. May repeat in 5 to 10 minutes up to a maximum of 0.1 mg/kg or 4 mg total, whichever is less.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution. Lower doses may be necessary.
* **Renal Impairment:** No specific dose adjustment is usually required, but caution is advised.
* **Elderly:** Start with lower doses (e.g., 0.5 mg orally once or twice daily) due to increased sensitivity to adverse effects.
### Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
### Adverse Effects
* **Common:** Drowsiness, dizziness, weakness, fatigue, ataxia.
* **Serious:** Respiratory depression, paradoxical reactions (e.g., increased agitation, aggression), anterograde amnesia, dependence, withdrawal symptoms upon abrupt discontinuation.
### Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Potentiates CNS depression, increasing the risk of severe sedation, respiratory depression, and death.
* **Theophylline, Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam levels.
### Monitoring
* Level of consciousness and sedation.
* Respiratory rate and oxygen saturation, especially with IV/IM administration or in combination with other CNS depressants.
* Signs of dependence or withdrawal if used chronically.
* Mental status and mood changes.
### Clinical Pearls
* Lorazepam has a relatively rapid onset of action, particularly with parenteral administration.
* Due to its intermediate half-life, it is suitable for managing anxiety and short-term insomnia.
* Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms. Tapering is recommended.
* Intramuscular (IM) absorption can be variable; intravenous (IV) administration offers more predictable absorption but carries a higher risk of respiratory depression.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information or a qualified healthcare provider for diagnosis and treatment.
